Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Zosano Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares
-
INSURANCE ACQUISITION CORP. COMMON STOCK AND WARRANTS TO COMMENCE TRADING SEPARATELY ON MAY 13, 2019
-
INSURANCE ACQUISITION CORP. COMMON STOCK AND WARRANTS TO COMMENCE TRADING SEPARATELY ON MAY 13, 2019
-
Mustang Bio Announces Full Exercise of Option
-
Mustang Bio Announces Full Exercise of Option
-
Correvio Reports First Quarter 2019 Financial Results
-
Health Insurance Innovations (HIIQ) 10Q Disclosure Indicates Investor Concerns Are Overblown - Cantor
-
eHealth (EHTH) PT Raised to Street High $100 at Cantor Fitzgerald, Target is ~51% Above Current Spot Price
-
Sleepy equity options jolted by renewed U.S.-China trade tensions
-
Makor Group Continues Growth With Two Senior Hires in London Office
-
GW Pharma (GWPH) PT Raised to $229 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Omeros Corp. (OMER) at Overweight
-
Mereo BioPharma Group plc (“Mereo” or the “Company” or the “Group”) Intention to Purchase Shares by Trustee of Employee Benefit Trust
-
Mereo BioPharma Group plc (“Mereo” or the “Company” or the “Group”) Intention to Purchase Shares by Trustee of Employee Benefit Trust
-
Cantor Fitzgerald Downgrades Worldplay Inc. (WP) to Neutral
-
Teva Pharma (TEVA) PT Lowered to $16 at Cantor Fitzgerald
-
Heron Therapeutics (HRTX) PT Lowered to $41 at Cantor Fitzgerald
-
Humana (HUM) PT Lowered to $283 at Cantor Fitzgerald
-
Act II Global Acquisition Corp. Announces Closing of $300,000,000 Initial Public Offering
-
Mustang Bio (MBIO) Prices 6.875M Shares at $4
-
Mustang Bio Announces Pricing of Public Offering of Common Stock
-
Mustang Bio Announces Pricing of Public Offering of Common Stock
-
Mustang Bio (MBIO) to Offer Common Stock
-
Mustang Bio Announces Proposed Public Offering of Common Stock
-
Mustang Bio Announces Proposed Public Offering of Common Stock
-
Form 13F-HR CANTOR FITZGERALD INVEST For: Mar 31
-
Pre-Open Stock Movers 04/26: (PETX) (MAT) (PRO) Higher; (BGG) (ATEN) (INTC) Lower (more...)
-
Mereo Biopharma to Announce Preliminary Results for the Full Year 2018 and Host Conference Call on April 29, 2019
-
Mereo Biopharma to Announce Preliminary Results for the Full Year 2018 and Host Conference Call on April 29, 2019
-
After-Hours Movers 04/25: (MAT) (EHTH) (PRO) Higher; (ATEN) (INTC) (BEAT) (more...)
-
Orchid Island Capital Announces First Quarter 2019 Results
-
Cantor Fitzgerald Starts Tocagen Inc. (TOCA) at Overweight
-
Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Admission to trading on AIM of New Shares and initiation of trading on Nasdaq of American Depositary Shares
-
Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Admission to trading on AIM of New Shares and initiation of trading on Nasdaq of American Depositary S
-
Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Completion of the Merger with OncoMed Pharmaceuticals, Inc.
-
Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Completion of the Merger with OncoMed Pharmaceuticals, Inc.
-
Pre-Open Stock Movers 04/23: (GNC) (HAS) (TWTR) Higher; (MBRX) (WAT) (HRL) Lower (more...)
-
Viking Energy Group Introduces Experienced and Successful Operations & Technical Team in Oil and Gas
-
Viking Energy Group Introduces Experienced and Successful Operations & Technical Team in Oil and Gas
-
After-Hours Movers 04/22: (CMRE) (WHR) (ZSAN) Higher; (GRTS) (RMBS) (more...)
-
Cantor Fitzgerald Starts Zosano Pharma (ZSAN) at Overweight
-
Brainsway Ltd. Announces Closing of Initial Public Offering
-
Brainsway Ltd. Announces Closing of Initial Public Offering
-
Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Merger Update: Acquisition of OncoMed Pharmaceuticals, Inc. ("OncoMed") – Result of OncoMed Stockholder Meeting
-
Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Merger Update: Acquisition of OncoMed Pharmaceuticals, Inc. ("OncoMed") – Result of OncoMe
-
Orchid Island Capital Announces April 2019 Monthly Dividend and March 31, 2019 RMBS Portfolio Characteristics
-
Brainsway Ltd. (BWAY) Prices 2.5M ADS IPO at $11/ADS
-
Brainsway Ltd. Announces Pricing of Initial Public Offering of 2.5 Million American Depositary Shares
-
UPDATE: Cantor Fitzgerald Upgrades HMS Holdings (HMSY) to Overweight
-
Cantor Fitzgerald Defends UnitedHealth Group (UNH)

